Latham & Watkins advises Gurnet Point Capital in acquisition of Paratek Pharmaceuticals.Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
